Sangamo (SGMO) shares are up 33c, or 53%, to 95c in after-hours trading after the company announced the deal with Eli Lilly (LLY).
Protect Your Portfolio Against Market Uncertainty
- Discover companies with rock-solid fundamentals in TipRanks' Smart Value Newsletter.
- Receive undervalued stocks, resilient to market uncertainty, delivered straight to your inbox.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on SGMO:
- Sangamo announces capsid license agreement with Eli Lilly
- 3 Best Stocks to Buy Now, 3/19/2025, According to Top Analysts
- Sangamo Biosciences: Navigating Competitive Pressures and Strategic Risks in Genomic Medicine
- Sangamo Biosciences’ Earnings Call Highlights Progress and Challenges
- 3 Best Stocks to Buy Now, 3/18/2025, According to Top Analysts